Dave is Co-founder, Chairman, President and CTO and a seasoned med-device executive with 20 years experience working in the medical device and interventional neurovascular industry.

Prior to co-founding Blockade Medical, he served as VP Product Development/Clinical Research & General Manager of MindFrame Inc. (acquired by Covidien in 2012), a developer, manufacturer and marketer of minimally invasive products for the treatment of AIS.

Marc is Co-founder and EVP EMEA. With close to 30 years in medical device sales and distribution in Europe, Marc has a rich network of contacts and an in-depth knowledge of medical devices specific to the neurovascular field. Marc was the first European distributor for Target Therapeutics, which was later acquired by Boston Scientific. After Target, Marc has represented a long list of the neurovascular markets most successful companies.

Ryan is the VP of Global Marketing and Business Development at Blockade Medical and has more than 10 years of medical sales and marketing expertise including extensive interventional neurovascular experience.

Ryan has successfully launched many products in the neurovascular field including launching the first flow diversion device in the United States while serving as the Group Marketing Manager at Covidien Neurovascular and global launch.

Jake is currently the Director of R&D at Blockade Medical. He has been in the medical device industry for over 8 years. Prior to joining Blockade Medical, Jake served as a Senior R&D Engineer at Microvention, developing neuroendovascular technologies to treat cerebral aneurysms.

Jake has held diverse positions in the medical device industry, which includes Manufacturing Engineer at Microvention, Manufacturing Engineer at Abbott Vascular.

Randall is the Director of Manufacturing at Blockade Medical and has been working in the medical device industry for 10 years. He has a wide breadth of manufacturing experience in different medical device fields. Prior to Blockade Medical, he served as a Sr. Engineer overseeing the Manufacturing and Operations department at MindFrame, Inc. (acquired by Covidien in 2012), a manufacturer of products for the treatment of acute ischemic stroke.